In a complex modern-day global supply chain, how can companies assess which suppliers present the highest level of risk to business continuity? And how can they begin to implement effective risk-management programs based on end-to-end visibility?
Instead of the two to three weeks taken by current treatments from American and European drug makers, a Shanghai-based company is churning out cancer-killing immune cells overnight.
Papa & Barkley, maker of cannabis-based wellness products, navigates a steep growth trajectory with MRP software designed specifically for small companies.
Inspections of foreign drug manufacturers by the U.S. Food and Drug Administration have fallen in recent years despite increasing worry about the safety and quality of generic medications, congressional investigators said.
Until recently, the big worry associated with cyberattacks was data loss. The NotPetya strike shows how a few hundred lines of malicious code can bring a company to its knees.
Among the dangers are a decline in cross-border investment, disruption in the supply chain and decreased collaboration in fields like artificial intelligence, wireless technology and cancer research.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.